{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:26Z","timestamp":1761515426852,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.4158\/ep.13.2.169","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:43:04Z","timestamp":1365198184000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Granulomatous Adenohypophysitis after Interferon and Ribavirin Therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Peter J.","family":"Tebben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.D.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd W.","family":"Scheithauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.13.2.169_bb0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"(Hepatitis Interventional Therapy Group). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.13.2.169_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.323.7322.1151","article-title":"Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials","volume":"323","author":"Kjaergard","year":"2001","journal-title":"BMJ"},{"key":"10.4158\/EP.13.2.169_bb0015","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.13.2.169_bb0020","first-page":"1925","article-title":"Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment","volume":"86","author":"Carella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.13.2.169_bb0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/eje.0.1460743","article-title":"The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism","volume":"146","author":"Carella","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP.13.2.169_bb0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2002.01553.x","article-title":"Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis","volume":"56","author":"Wong","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.13.2.169_bb0035","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/archinte.164.21.2371","article-title":"Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study","volume":"164","author":"Bini","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP.13.2.169_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2005.01089.x","article-title":"Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C","volume":"25","author":"Doi","year":"2005","journal-title":"Liver Int"},{"key":"10.4158\/EP.13.2.169_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4158\/EP.11.2.135","article-title":"Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C","volume":"11","author":"Lin","year":"2005","journal-title":"Endocr Pract"},{"key":"10.4158\/EP.13.2.169_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2893.2000.00247.x","article-title":"Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus","volume":"7","author":"Parana","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.4158\/EP.13.2.169_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2169\/internalmedicine.35.376","article-title":"Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C","volume":"35","author":"Nakajima","year":"1996","journal-title":"Intern Med"},{"key":"10.4158\/EP.13.2.169_bb0060","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archderm.141.7.865","article-title":"Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature","volume":"141","author":"Hurst","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.4158\/EP.13.2.169_bb0065","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1023\/A:1015843908536","article-title":"Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature","volume":"47","author":"Nawras","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.4158\/EP.13.2.169_bb0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.138.4.546","article-title":"Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C","volume":"138","author":"Wendling","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.4158\/EP.13.2.169_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004728-200303000-00030","article-title":"Interferon-induced sarcoidosis","volume":"27","author":"Rubinowitz","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"10.4158\/EP.13.2.169_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1378\/chest.116.2.569","article-title":"Interferon-alpha therapy associated with the development of sarcoidosis","volume":"116","author":"Pietropaoli","year":"1999","journal-title":"Chest"},{"key":"10.4158\/EP.13.2.169_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2169\/internalmedicine.35.19","article-title":"Sarcoidosis after interferon therapy for chronic active hepatitis C","volume":"35","author":"Teragawa","year":"1996","journal-title":"Intern Med"},{"key":"10.4158\/EP.13.2.169_bb0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00042737-200208000-00013","article-title":"Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases","volume":"14","author":"Gitlin","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5 Pt 2","key":"10.4158\/EP.13.2.169_bb0095","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/01.AOG.0000157764.44292.aa","article-title":"Uterine sarcoidosis potentially associated with interferon-alpha use for chronic hepatitis C infection","volume":"105","author":"Tsiodras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP.13.2.169_bb0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.pas.0000160442.23523.0a","article-title":"Pulmonary sarcoidosis induced by interferon-alpha therapy","volume":"29","author":"Butnor","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.4158\/EP.13.2.169_bb0105","first-page":"CS5","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C","volume":"10","author":"Papaioannides","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.4158\/EP.13.2.169_bb0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/00365540310016024","article-title":"Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases [letter]","volume":"35","author":"Luchi","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.4158\/EP.13.2.169_bb0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000052147","article-title":"Neurosarcoidosis associated with interferon therapy","volume":"45","author":"Miwa","year":"2001","journal-title":"Eur Neurol"},{"key":"10.4158\/EP.13.2.169_bb0120","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(95)90950-8","article-title":"Reversible hypopituitarism after interferonalfa therapy [letter]","volume":"345","author":"Sakane","year":"1995","journal-title":"Lancet"},{"key":"10.4158\/EP.13.2.169_bb0125","first-page":"519","article-title":"Pituitary involvement by Wegener\u2019s granulomatosis: a report of two cases","volume":"20","author":"Katzman","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.4158\/EP.13.2.169_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1995.tb01882.x","article-title":"Two cases of Wegener\u2019s granulomatosis involving the pituitary","volume":"42","author":"Roberts","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.13.2.169_bb0135","first-page":"1466","article-title":"Granulomatous hypophysitis due to Wegener\u2019s granulomatosis","volume":"21","author":"Goyal","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.4158\/EP.13.2.169_bb0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/030097400750041433","article-title":"Sudden death and Wegener\u2019s granulomatosis of the pituitary","volume":"29","author":"Woywodt","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.4158\/EP.13.2.169_bb0145","first-page":"220","article-title":"Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass","volume":"315","author":"Guoth","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.4158\/EP.13.2.169_bb0150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0899-7071(98)00035-7","article-title":"Neurosarcoidosis presenting as a large suprasellar mass: magnetic resonance imaging findings","volume":"22","author":"Bakshi","year":"1998","journal-title":"Clin Imaging"},{"key":"10.4158\/EP.13.2.169_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s701-002-8273-5","article-title":"Inflammatory hypophysitis\u2014 the spectrum of disease","volume":"144","author":"Flanagan","year":"2002","journal-title":"Acta Neurochir (Wien)"},{"key":"10.4158\/EP.13.2.169_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00006123-199807000-00092","article-title":"Granulomatous hypophysitis caused by a ruptured intrasellar Rathke\u2019s cleft cyst: report of a case and review of the literature","volume":"43","author":"Roncaroli","year":"1998","journal-title":"Neurosurgery"},{"key":"10.4158\/EP.13.2.169_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2265.1996.8110821.x","article-title":"Granulomatous hypophysitis associated with Takayasu\u2019s disease","volume":"45","author":"Toth","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP.13.2.169_bb0170","first-page":"136","article-title":"Sellar granulomatous mass in a pregnant woman with active Crohn\u2019s disease","volume":"39","author":"de Bruin","year":"1991","journal-title":"Neth J Med"},{"key":"10.4158\/EP.13.2.169_bb0175","first-page":"299","article-title":"Pituitary tuberculoma\u2014a case report","volume":"49","author":"Manghani","year":"2001","journal-title":"Neurol India"},{"key":"10.4158\/EP.13.2.169_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0303-8467(00)00063-9","article-title":"Intrasellar tuberculoma\u2014an enigmatic pituitary infection: a series of 18 cases","volume":"102","author":"Sharma","year":"2000","journal-title":"Clin Neurol Neurosurg"},{"key":"10.4158\/EP.13.2.169_bb0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/0028-3886.16950","article-title":"A solitary cryptococcal granuloma in an immunocompetent host [letter]","volume":"53","author":"Nadkarni","year":"2005","journal-title":"Neurol India"},{"key":"10.4158\/EP.13.2.169_bb0190","first-page":"9","article-title":"Sindromi ipofisarie Malattia del Simmond e coma pituitario del Miermet","volume":"44","author":"Pennetti","year":"1928","journal-title":"La Riforma Medica"},{"key":"10.4158\/EP.13.2.169_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2176\/nmc.40.532","article-title":"Langerhans cell histiocytosis limited to the pituitary-hypothalamic axis\u2014two case reports","volume":"40","author":"Isoo","year":"2000","journal-title":"Neurol Med-Chir (Tokyo)"},{"key":"10.4158\/EP.13.2.169_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0303-8467(95)00010-H","article-title":"Gagel\u2019s granuloma (localized Langerhans cell histiocytosis) in the pituitary stalk","volume":"97","author":"Scholz","year":"1995","journal-title":"Clin Neurol Neurosurg"},{"key":"10.4158\/EP.13.2.169_bb0205","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jcem.86.3.7265","article-title":"The spectrum and significance of primary hypophysitis","volume":"86","author":"Cheung","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.13.2.169_bb0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00006123-199704000-00010","article-title":"Lymphocytic and granulomatous hypophysitis: experience with nine cases [with discussion]","volume":"40","author":"Honegger","year":"1997","journal-title":"Neurosurgery"},{"key":"10.4158\/EP.13.2.169_bb0215","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00006123-199902000-00130","article-title":"Lymphocytic and granulomatous hypophysitis: experience with nine cases [letter]","volume":"44","author":"Mueller","year":"1999","journal-title":"Neurosurgery"},{"key":"10.4158\/EP.13.2.169_bb0220","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00006123-200005000-00053","article-title":"Lymphocytic and granulomatous hypophysitis: experience with nine cases [letter]","volume":"46","author":"Gazioglu","year":"2000","journal-title":"Neurosurgery"},{"key":"10.4158\/EP.13.2.169_bb0225","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s002340000481","article-title":"Idiopathic granulomatous hypophysitis: are there reliable, constant radiological and clinical diagnostic criteria?","volume":"42","author":"Gazioglu","year":"2000","journal-title":"Neuroradiology"},{"key":"10.4158\/EP.13.2.169_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3171\/jns.2004.101.2.0262","article-title":"Primary hypophysitis: a single-center experience in 16 cases","volume":"101","author":"Leung","year":"2004","journal-title":"J Neurosurg"},{"key":"10.4158\/EP.13.2.169_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02738885","article-title":"Xanthomatous hypophysitis: a novel entity of obscure etiology","volume":"10","author":"Deodhare","year":"1999","journal-title":"Endocr Pathol"},{"key":"10.4158\/EP.13.2.169_bb0240","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2176\/nmc.37.766","article-title":"Giant cell granulomatous hypophysitis manifesting as an intrasellar mass with unilateral ophthalmoplegia\u2014case report","volume":"37","author":"Inoue","year":"1997","journal-title":"Neurol Med-Chir (Tokyo)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20414417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20414417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/B917453R02741862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:20Z","timestamp":1761515240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20414417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1530891X20414417"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.2.169","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulomatous Adenohypophysitis after Interferon and Ribavirin Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.2.169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}